Figure S1. Levels of mTOR and RPS6 in GD NPCs. A) Representative western blot showing mTOR and RPS6 protein levels in control and GD2 NPCs. B) Bar graph represents fold mTOR in GD2 NPCs (GD2a and GD2b combined) relative to control. Data are mean ±s.e.m, n= 3-4 per group. p>0.05 between control and GD2a and GD2b as assessed by Student's t-test. C) Bar graph represents fold RPS6 in GD2 NPCs (GD2a and GD2b combined) relative to control. Data are mean ±s.e.m, n= 3-4 per group. p>0.05 between control and GD2a and GD2b as assessed by Student's t-test.
. Increased p-RPS6 protein levels in GD NPCs. A) Representative immunofluorescence images of control and GD2b NPCs labeled with antibodies to RPS6 (top) or p-RPS6 (bottom) and DAPI. Magnification 20x; scale bar, 100 µm. B) Representative immunofluorescence images of control and GD2a NPCs labeled with an antibody to p-RPS6 and DAPI. Cells were either untreated (NT) or treated with 100 nM Torin1 for 6 hours. Magnification 20x; scale bar, 100 µm. Bar graph to the right represents mean p-RPS6 fluorescence signal intensity in control and GD NPCs (GD2a and GD2b combined) with and without Torin1. Data were collected from >100 cells per group, assayed in 3-5 different fields in a representative experiment. Error bars = s.e.m., **p<0.005 and ****p<0.00005 between the indicated groups as assessed by One-way ANOVA. 
